Albuminuria, Proteinuria, and Renal Disease Progression in Children with CKD

被引:57
作者
Fuhrman, Dana Y.
Schneider, Michael F.
Dell, Katherine M.
Blydt-Hansen, Tom D.
Mak, Robert
Saland, Jeffrey M.
Furth, Susan L.
Warady, Bradley A.
Moxey-Mims, Marva M.
Schwartz, George J.
机构
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2017年 / 12卷 / 06期
关键词
CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; COLLABORATIVE METAANALYSIS; HIGH-RISK; CARDIOVASCULAR EVENTS; URINARY ALBUMIN; EXCRETION RATE; ALL-CAUSE; MICROALBUMINURIA; PREDICTORS;
D O I
10.2215/CJN.11971116
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives The role of albuminuria as an indicator of progression has not been investigated in children with CKD in the absence of diabetes. Design, setting, participants, & measurements Children were enrolled from 49 centers of the CKD in Children study between January of 2005 and March of 2014. Cross-sectional multivariable linear regression (n=647) was used to examine the relationship between urine protein-to-creatinine (UP/C [milligrams per milligram]) and albumin-to-creatinine (ACR [milligrams per gram]) with eGFR (milliliters per minute per 1.73 m(2)). Parametric time-to-event analysis (n=751) was used to assess the association of UP/C, ACR, and urine nonalbumin-tocreatinine (Unon-alb/cr [milligrams per gram]) on the time to the composite endpoint of initiation of RRT or 50% decline in eGFR. Results The median follow-up time was 3.4 years and 202 individuals experienced the event. Participants with a UP/C >= 0.2 mg/mg and ACR >= 30 mg/g had a mean eGFR that was 16 ml/min per 1.73 m2 lower than those with a UP/C<0.2 mg/mg and ACR<30 mg/g. Individuals with ACR<30 mg/g, but a UP/C >= 0.2 mg/mg, had a mean eGFR that was 9.3 ml/min per 1.73 m2 lower than those with a UP/C<0.2 mg/mg. and ACR<30 mg/g. When categories of ACR and Unon-alb/cr were created on the basis of clinically meaningful cutoff values of UP/C with the same sample sizes for comparison, the relative times (RTs) to the composite end-point were almost identical when comparing the middle (RT=0.31 for UP/C [0.2-2.0 mg/mg], RT=0.38 for ACR [56-1333 mg/g], RT=0.31 for Unon-alb/cr [118-715 mg/g]) and the highest (RT=0.08 for UP/C [>2.0 mg/mg], RT=0.09 for ACR [>1333 mg/g], RT=0.07 for Unon-alb/cr [>715 mg/g]) levels to the lowest levels. A similar trend was seen when categories were created on the basis of clinically meaningful cutoff values of ACR (<30, 30-300, >300 mg/g). Conclusions In children with CKD without diabetes, the utility of an initial UP/C, ACR, and Unon-alb/cr for characterizing progression is similar.
引用
收藏
页码:912 / 920
页数:9
相关论文
共 50 条
  • [31] BLOOD-PRESSURE CONTROL, PROTEINURIA, AND THE PROGRESSION OF RENAL-DISEASE - THE MODIFICATION OF DIET IN RENAL-DISEASE STUDY
    PETERSON, JC
    ADLER, S
    BURKART, JM
    GREENE, T
    HEBERT, LA
    HUNSICKER, LG
    KING, AJ
    KLAHR, S
    MASSRY, SG
    SEIFTER, JL
    ANNALS OF INTERNAL MEDICINE, 1995, 123 (10) : 754 - +
  • [32] Chronic Kidney Disease and Albuminuria in Children with Sickle Cell Disease
    Yee, Marianne McPherson
    Jabbar, Shameem F.
    Osunkwo, Ifeyinwa
    Clement, Lisa
    Lane, Peter A.
    Eckman, James R.
    Guasch, Antonio
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (11): : 2628 - 2633
  • [33] Biological Variability of Estimated GFR and Albuminuria in CKD
    Waikar, Sushrut S.
    Rebholz, Casey M.
    Zheng, Zihe
    Hurwitz, Shelley
    Hsu, Chi-Yuan
    Feldman, Harold, I
    Xie, Dawei
    Liu, Kathleen D.
    Mifflin, Theodore E.
    Eckfeldt, John H.
    Kimmel, Paul L.
    Vasan, Ramachandran S.
    Bonventre, Joseph, V
    Inker, Lesley A.
    Coresh, Josef
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 72 (04) : 538 - 546
  • [34] Renal microvascular dysfunction, hypertension and CKD progression
    Bidani, Anil K.
    Polichnowski, Aaron J.
    Loutzenhiser, Rodger
    Griffin, Karen A.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2013, 22 (01) : 1 - 9
  • [35] Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study
    Grams, Morgan E.
    Yang, Wei
    Rebholz, Casey M.
    Wang, Xue
    Porter, Anna C.
    Inker, Lesley A.
    Horwitz, Edward
    Sondheimer, James H.
    Hamm, L. Lee
    He, Jiang
    Weir, Matthew R.
    Jaar, Bernard G.
    Shafi, Tariq
    Appel, Lawrence J.
    Hsu, Chi-yuan
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 70 (03) : 337 - 346
  • [36] Clinical implications of the CKD epidemiology collaboration (CKD-EPI) equation compared with the modification of diet in renal disease (MDRD) study equation for the estimation of renal dysfunction in patients with cardiovascular disease
    Tarantini, Luigi
    Barbati, Giulia
    Cioffi, Giovanni
    McAlister, Finlay Aleck
    Ezekowitz, Justin Adrian
    Mazzone, Carmine
    Faganello, Giorgio
    Russo, Giulia
    Grisolia, Enrico Franceschini
    Di Lenarda, Andrea
    INTERNAL AND EMERGENCY MEDICINE, 2015, 10 (08) : 955 - 963
  • [37] Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from theLEADERrandomized trial
    Mosenzon, Ofri
    Bain, Stephen C.
    Heerspink, Hiddo J. L.
    Idorn, Thomas
    Mann, Johannes F. E.
    Persson, Frederik
    Pratley, Richard E.
    Rasmussen, Soren
    Rossing, Peter
    von Scholten, Bernt Johan
    Raz, Itamar
    DIABETES OBESITY & METABOLISM, 2020, 22 (11) : 2077 - 2088
  • [38] Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality
    Carrero, Juan Jesus
    Grams, Morgan E.
    Sang, Yingying
    Arnlov, Johan
    Gasparini, Alessandro
    Matsushita, Kunihiro
    Qureshi, Abdul R.
    Evans, Marie
    Barany, Peter
    Lindholm, Bengt
    Ballew, Shoshana H.
    Levey, Andrew S.
    Gansevoort, Ron T.
    Elinder, Carl G.
    Coresh, Josef
    KIDNEY INTERNATIONAL, 2017, 91 (01) : 244 - 251
  • [39] Progression of Diabetic Kidney Disease in the Absence of Albuminuria
    MacIsaac, Richard J.
    Ekinci, Elif I.
    DIABETES CARE, 2019, 42 (10) : 1842 - 1844
  • [40] Myeloperoxidase and the Risk of CKD Progression, Cardiovascular Disease, and Death in the Chronic Renal Cohort (CRIC)
    Correa, Simon
    Pena-Esparragoza, Jessy Korina
    Scovner, Katherine M.
    Waikar, Sushrut S.
    Mc Causland, Finnian R.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 76 (01) : 32 - 41